Solid form of FXR agonist

Abstract

This provides a method for treating liver disease. [Solution] Novel solid forms of the FXR agonist of formula (I) are disclosed. The disclosure also relates to pharmaceutical compositions containing one or more of the disclosed solid forms, and to methods of using these solid forms in the treatment of FXR-mediated conditions. The disclosure also relates to methods for obtaining such solid forms. In some embodiments, the disclosed compounds or compositions are provided for the manufacture of pharmaceuticals for the treatment of FXR-mediated conditions. TIFF2026097927000045.tif3967

Claims

[Claim 1] Liver disease.

Images